Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20355)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | GR50 | GRmax | GR_AOC | GEC50 | GRinf | GR Hill Coefficient | GR r2 | pval_GR |
---|---|---|---|---|---|---|---|---|---|
HCC1806 | Ulixertinib | 37.8339826121 | 0.7126 | 0.0346 | 196.9739 | -1.0000 | 0.6659 | 0.6968 | 3.32864045105e-07 |
BT-20 | THZ531 | 1.39952715577 | 0.5663 | 0.0377 | 3.3807 | -1.0000 | 1.2457 | 0.6737 | 8.31588281125e-07 |
CAL-51 | RO-3306 | 8.346101408 | 0.1772 | 0.0379 | 11.9039 | -1.0000 | 3.0941 | 0.9243 | 9.77e-15 |
MCF 10A | Rucaparib | 365.312204082 | 0.8656 | 0.0388 | 751.5036 | -0.2094 | 0.4850 | 0.5902 | 1.43637187561e-05 |
BT-549 | Rucaparib | inf | 0.8808 | 0.0404 | 0.0000 | 0.9550 | 0.0100 | 0.0000 | 1.0 |
SUM149PT | GSK2334470 | 25.76380861 | 0.6531 | 0.0406 | 118.2600 | -1.0000 | 0.7209 | 0.5628 | 3.22e-05 |
HCC38 | GSK2334470 | 362.2276812 | 0.7326 | 0.0411 | 1000.0000 | -0.2309 | 0.3738 | 0.3294 | 0.006774661 |
T47D | Rucaparib | inf | 0.8130 | 0.0415 | 0.0000 | 0.9307 | 0.0100 | 0.0000 | 0.073451061 |
HCC1419 | SHP099 | inf | 0.7338 | 0.0420 | 0.0000 | 0.9489 | 0.0100 | 0.0000 | 0.203508371 |
SUM159PT | SHP099 | 3294.604776 | 0.8118 | 0.0447 | 1000.0000 | 0.1710 | 0.3511 | 0.3261 | 0.007206359 |
HCC1937 | SHP099 | inf | 0.7745 | 0.0470 | 0.0000 | 0.9312 | 0.0100 | 0.0000 | 1.0 |
SUM159PT | THZ531 | 1.158729591 | 0.6103 | 0.0475 | 1.7617 | -1.0000 | 2.6222 | 0.8700 | 8.37e-12 |
HCC38 | RO-3306 | 7.435051917 | -0.2110 | 0.0493 | 9.2621 | -1.0000 | 5.0000 | 0.9513 | 1.11e-16 |
HCC1143 | Rucaparib | 212371.6019 | 0.7856 | 0.0507 | 630.9562 | 0.3840 | 0.2511 | 0.2497 | 0.027576264 |
MDA-MB-157 | AZD5363 | inf | 0.6671 | 0.0508 | 0.0000 | 0.9480 | 0.0100 | 0.0000 | 0.135243927 |
HME1 | RO-3306 | 4.087843972 | -0.0172 | 0.0517 | 4.0640 | 0.0144 | 5.0000 | 0.9574 | 1.11e-16 |
MCF 10A | Rucaparib | inf | 0.8695 | 0.0527 | 79.7513 | 0.7576 | 0.2151 | 0.3749 | 0.002812424 |
HCC1806 | AZD5363 | 1097.05246074 | 0.6869 | 0.0528 | 1000.0000 | 0.0138 | 0.3031 | 0.3511 | 0.00448557172627 |
HCC1143 | SHP099 | 1449.842823 | 0.7869 | 0.0529 | 1000.0000 | 0.0556 | 0.3172 | 0.3933 | 0.001935462 |
HCC1954 | RO-3306 | 6.64148500206 | -0.1134 | 0.0533 | 9.5343 | -1.0000 | 3.0385 | 0.9127 | 5.7620574978e-14 |
SUM1315MO2 | AZD6738 | 4.435414924 | -0.1764 | 0.0538 | 8.3060 | -1.0000 | 1.7512 | 0.8774 | 4.02e-12 |
HCC1419 | Rucaparib | inf | 0.8069 | 0.0539 | 0.0000 | 0.9485 | 0.0100 | 0.0000 | 0.337916631 |
AU565 | AZD6738 | 9.117192222 | 0.2755 | 0.0564 | 11.3576 | -1.0000 | 5.0000 | 0.7383 | 5.27e-08 |
CAMA-1 | MK 1775 | 5.412146559 | -0.2519 | 0.0565 | 8.5802 | -1.0000 | 2.3841 | 0.7821 | 5.36e-09 |
CAL-51 | Ulixertinib | 20.08181132 | 0.7439 | 0.0569 | 48.1868 | -0.9997 | 1.2549 | 0.4674 | 0.000380369 |